Particle Data Platform

Ibogaine Isn’t Ready Yet

14:4316:01 · 78s

Stone flags ibogaine’s limited data and safety risks despite Trump’s enthusiasm, warning against rushing approvals and noting upcoming FDA priority review plans.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.